A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Clinical trial NCT07182149 · RECRUITING

Trial details

NCT number: NCT07182149
Sponsor: Normunity AccelCo, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HNSCC ESCC Esophageal Adenocarcinoma Gastric Adenocarcinoma GEJ Adenocarcinoma Ovarian Cancer NSCLC Cervical Cancer Endometrial Cancer Triple Negative Breast Cancer (TNBC)

Start date: 2025-10-30
Primary completion: 2027-05-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.